Yingzhou Shi
Overview
Explore the profile of Yingzhou Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Hu T, Zhang R, Shi Y, Wang Y, Xuan Q, et al.
Biochem Biophys Res Commun
. 2025 Mar;
756:151583.
PMID: 40054063
Obesity, a significant risk factor for cardiovascular diseases, induces cardiolipin (CL) remodeling. Acyl-CoA:lysocardiolipin acyltransferase-1 (ALCAT1), a key enzyme in CL metabolism, drives mitochondrial impairment and cardiac dysfunction in obesity. Although...
2.
Wu Y, Fan X, Shi Y, Yuan Z, Zhang Y, Han J, et al.
BMJ Public Health
. 2025 Feb;
3(1):e001539.
PMID: 40017947
Abstracts: Introduction: This study aimed to examine the risk of common diseases among people with pre-diabetes and explored the relationship between pre-diabetes and multimorbidity (in this case, two or more...
3.
Dong H, Shi Y, Ma Y, Cheng Y, Liu L, Xiao S, et al.
Diabetes Obes Metab
. 2025 Feb;
PMID: 39972192
Aims: The growing epidemic of overweight and obesity elevates disease risks, with metabolic disorders and inflammation critically involved in the pathogenic mechanisms. This study refines the subtyping of overweight and...
4.
Liu L, Shi Y, Li Y, Wu W, Tian Y, Fan X, et al.
J Glob Health
. 2024 Dec;
14:04249.
PMID: 39651662
Background: Rare endocrine diseases (RED) often pose chronic and life-threatening challenges, yet their economic costs and societal impact remains have not been precisely quantified. Methods: We obtained patient data from...
5.
Yuan Z, Ding C, Duan J, Lian R, Shi Y, Han J, et al.
iScience
. 2024 Sep;
27(9):110680.
PMID: 39252980
Cancer prevention is a serious global challenge. We aimed to investigate the relationship between lipid-lowering drugs and cancers. We included participants based on the UK Biobank. Lipid-lowering drug use was...
6.
Shi Y, Yuan G, Fan X, Xu C
Clin Mol Hepatol
. 2024 Apr;
30(4):987-988.
PMID: 38637982
No abstract available.
7.
Liu L, Shi Y, Fan X, Yao Y, Wu W, Tian Y, et al.
Orphanet J Rare Dis
. 2024 Mar;
19(1):99.
PMID: 38438867
Background: Most genetic skeletal disorders (GSD) were complex, disabling and life-threatening without effective diagnostic and treatment methods. However, its impacts on health system have not been well studied. The study...
8.
Fan X, Zhang B, Shi Y, Liu L, Zhao J
J Hepatol
. 2024 Feb;
80(6):e246-e248.
PMID: 38311122
No abstract available.
9.
Tian Y, Liu L, Li Y, Fan X, Wu W, Shi Y, et al.
Front Physiol
. 2023 Dec;
14:1290611.
PMID: 38089474
There is an inconsistent association between overweight/obesity and chronic obstructive pulmonary disease (COPD). Considering that different metabolic characteristics exist among individuals in the same body mass index (BMI) category, the...
10.
Shi Y, Dong H, Sun S, Wu X, Fang J, Zhao J, et al.
Clin Mol Hepatol
. 2023 Dec;
30(1):80-97.
PMID: 38061333
Background/aims: To evaluate the causal correlation between complement components and non-viral liver diseases and their potential use as druggable targets. Methods: We conducted Mendelian randomization (MR) to assess the causal...